Tianjin Medical University Cancer Institute and Hospital: all 490 studies

Page 1 of 5. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.

• Effect of Low-Dose Esketamine Combined With Dexmedetomidine on the Incidence of Chronic Postsurgical Pain in Patients Undergoing Pancreatic SurgeryNot yet recruitingNCT07888413Phase 4
• Umbilical Cord Blood Infusion to Promote Hematopoietic and Immune Reconstitution in Children With Relapsed or Refractory Malignant Solid TumorsNot yet recruitingNCT07866534Not applicable
• Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.Not yet recruitingNCT07854977Phase 2
• Fecal Microbiota Transplantation Combined With QL1706 Plus Bevacizumab for Advanced HCCNot yet recruitingNCT07847671Phase 2
• FMT Plus SHR-1701 With Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07845565Phase 2
• Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular CarcinomaRecruitingNCT07840092
• Hypofractionated Radiotherapy After Breast Reconstruction for Breast CancerNot yet recruitingNCT07831889Not applicable
• Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic CancerNot yet recruitingNCT07828756Phase 2
• Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Laparoscopic HepatectomyNot yet recruitingNCT07826806Phase 2
• SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic SarcomaNot yet recruitingNCT07817095Phase 2
• Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast CancerRecruitingNCT07817082Phase 2
• Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient AdherenceRecruitingNCT07817056
• Efficacy and Safety of Stereotactic Body Radiation Therapy for Spinal Metastases With Bilsky Grade 1c-3RecruitingNCT07809672Not applicable
• Phase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa With or Without CAPOX as Perioperative Therapy for Resectable Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07802288Phase 2
• Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCCRecruitingNCT07801287Phase 2
• Postoperative Edge (RapidArc) Stereotactic Body Radiotherapy for Spinal MetastasesRecruitingNCT07801274
• IRE After Chemotherapy for Locally Advanced Pancreatic CancerRecruitingNCT07799935Not applicable
• IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor ThrombusRecruitingNCT07799922Not applicable
• Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer ChemotherapyNot yet recruitingNCT07796906Not applicable
• HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar CholangiocarcinomaRecruitingNCT07795619Not applicable
• Baduanjin for Quality of Life in Pancreatic Cancer ChemotherapyNot yet recruitingNCT07791550Not applicable
• HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ PreservationRecruitingNCT07786493Not applicable
• Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.Not yet recruitingNCT07778940Phase 2
• A Prospective Phase II Clinical Trial Evaluating the Efficacy and Safety of Adebrelimab in Combination With Trastuzumab Rezetecan for Patients With Stage III Unresectable HER2-Positive NSCLCNot yet recruitingNCT07778745Phase 2
• Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT07778732Phase 2
• An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.RecruitingNCT07776821Phase 4
• A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal SurgeryNot yet recruitingNCT07751367Not applicable
• Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug and HAIC ConversionNot yet recruitingNCT07738055Not applicable
• To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Rectal Cancer Under MSS/pMMRNot yet recruitingNCT07738042Not applicable
• A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy and Safety of Trilaciclib in Preventing Myelosuppression Caused by Topoisomerase I Inhibitor Type ADC DrugsNot yet recruitingNCT07736001Not applicable
• Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCCRecruitingNCT07733830Phase 2
• A Phase II Exploratory Study of Sacituzumab Tirumotecan Combined With Envafolimab for TROP2-Positive Advanced Biliary Tract Cancers Previously Treated With First-Line Immunotherapy Combined With Chemotherapy.Not yet recruitingNCT07729033Phase 2
• Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct TumorsRecruitingNCT07726446Phase 2
• Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINVRecruitingNCT07726433Phase 2
• Multi-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCLNot yet recruitingNCT07724782Phase 1/2
• Butyrate Yogurt for Cancer ConstipationNot yet recruitingNCT07723729Phase 2
• Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07721103Phase 2
• AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine CancerNot yet recruitingNCT07712094Phase 2
• Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab FailureRecruitingNCT07708194Phase 1/2
• Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal CancerNot yet recruitingNCT07691632Phase 2
• Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial TumorsRecruitingNCT07691619Phase 2
• Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07689292Phase 2
• Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase IINot yet recruitingNCT07686926Phase 2
• Risk Stratification and Proactive Nursing Intervention for Acute Kidney Injury Following Interventional Therapy in Patients With Liver CancerNot yet recruitingNCT07681817Not applicable
• The Effect of Braun Anastomosis on Delayed Gastric Emptying (DGE) in Reconstruction After PancreaticoduodenectomyRecruitingNCT07681128Not applicable
• Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant ResponseNot yet recruitingNCT07670715Phase 2
• The Efficacy of Combined Peripheral Blood CTCs and Serum HER2 Detection in Docetaxel-based Treatment for HER2 Low-expression Breast CancerNot yet recruitingNCT07670182
• Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell CarcinomaRecruitingNCT07665190Phase 2
• Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer PatientsRecruitingNCT07634978Not applicable
• Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer SurgeryRecruitingNCT07632118Phase 3
• Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial NephrectomyNot yet recruitingNCT07627464Phase 2
• Specialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer SurgeryRecruitingNCT07622381Not applicable
• Surgical Total Clearance Versus Extrahepatic Bile Duct Preservation for Biliary Tract Malignancies: A Single-Center, Randomized, Two-Arm, Prospective Phase II Clinical TrialRecruitingNCT07609641Not applicable
• Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical TrialRecruitingNCT07594925Phase 2
• Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingNCT07591831Phase 2
• Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast CancerNot yet recruitingNCT07589972Not applicable
• Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)Not yet recruitingNCT07584031Phase 2
• The DoHAICs Study Expansion PhaseNot yet recruitingNCT07584018Phase 2
• Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesNot yet recruitingNCT07570914Phase 2
• Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation DeviceRecruitingNCT07561567
• Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular CarcinomaRecruitingNCT07560488Phase 2
• Exploratory Study of SHR-A1811 Via Different Administration Routes in PatientsNot yet recruitingNCT07560475Phase 2
• Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2)Not yet recruitingNCT07550920Phase 2
• A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based ChemotherapyRecruitingNCT07548060Phase 2
• Laparoscopic Staging for Stage III Gastric CancerEnrolling by invitationNCT07533825Not applicable
• Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2Not yet recruitingNCT07531979Phase 2
• Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy FailureRecruitingNCT07528274Phase 2
• Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow MarginNot yet recruitingNCT07518706Phase 2
• A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence RiskNot yet recruitingNCT07515469Phase 2
• A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NECNot yet recruitingNCT07510594Phase 2
• A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal CancerRecruitingNCT07506109Phase 2
• Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung CancerRecruitingNCT07505173Phase 2
• A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）Not yet recruitingNCT07496073Phase 1
• Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07493993Phase 2
• Retlirafusp Alfa Injection Combined Chemotherapy for Perioperative Treatment of Esophagogastric Junction Adenocarcinoma: A Single-Arm, Phase II Study of Safety and EfficacyNot yet recruitingNCT07493382Not applicable
• A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast CancerNot yet recruitingNCT07491822Not applicable
• A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of RecurrenceRecruitingNCT07475026Phase 3
• Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCCRecruitingNCT07457528Phase 2
• Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid TumorsNot yet recruitingNCT07444918Phase 2
• A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast CancerNot yet recruitingNCT07441486Phase 2
• Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLCNot yet recruitingNCT07438600Phase 2
• Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic CancerRecruitingNCT07436741Phase 3
• A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICCNot yet recruitingNCT07432568Phase 2
• Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant ChemotherapyNot yet recruitingNCT07410234Phase 2
• Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor TherapyEnrolling by invitationNCT07409298Not applicable
• Real-world Studies of CDK4/6 InhibitorsRecruitingNCT07407439
• CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCLRecruitingNCT07397832Phase 2
• Adebrelimab Neoadjuvant Treatment for Resectable ESCCNot yet recruitingNCT07388095Not applicable
• Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung CancerNot yet recruitingNCT07379398Phase 2
• Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With ChemotherapyRecruitingNCT07372079Phase 2
• Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety StudyNot yet recruitingNCT07365410Phase 2
• Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung CancerNot yet recruitingNCT07358689Phase 2
• A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung CancerRecruitingNCT07358676Phase 2
• A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid TumorsRecruitingNCT07351903Phase 1
• Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake StatusRecruitingNCT07350928Phase 3
• Serplulimab for Locally Advanced Cervical CancerRecruitingNCT07340489Phase 2
• Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk FactorsNot yet recruitingNCT07330076Phase 2
• Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal GastrectomyRecruitingNCT07330063Phase 2
• WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLCRecruitingNCT07330050Phase 2
• TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant ChemoimmunotherapyRecruitingNCT07330037Phase 2

← Tianjin Medical University Cancer Institute and Hospital overview and focus areas